Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)
source: pixabay.com

Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)

As shared by MedScape, the U.S. FDA recently approved the first treatment for people living with congenital thrombotic thrombocytopenic purpura (TTP). Its name? Adzynma. In the past, people with TTP…

Continue Reading Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)
Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis
source: pixabay.com

Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis

Give the gift of life this holiday season and consider donating your bone marrow to BeTheMatch. Each year, over 18,000 people are diagnosed with a life-threatening blood condition that could…

Continue Reading Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis
Wave Life Science’s New Trial Application is Causing Renewed Excitement Around RNA Editing
source: shutterstock.com

Wave Life Science’s New Trial Application is Causing Renewed Excitement Around RNA Editing

  If Wave Life Sciences’ recently submitted trial application for WVE-006 is approved, it will become the first RNA editing treatment in a clinical development setting. Wave’s CEO, Paul Bolno,…

Continue Reading Wave Life Science’s New Trial Application is Causing Renewed Excitement Around RNA Editing
Scientists Are Calling Monkey’s Two-Year Survival After a Pig Kidney Transplant “Unprecedented”
source: pixabay.com

Scientists Are Calling Monkey’s Two-Year Survival After a Pig Kidney Transplant “Unprecedented”

  The xenotransplant involved transplanting Yucatan miniature pig kidneys into macaque monkeys with 69 genetic modifications. One monkey survived for over two years, offering hope to the team of Harvard…

Continue Reading Scientists Are Calling Monkey’s Two-Year Survival After a Pig Kidney Transplant “Unprecedented”